Reported about 1 month ago
Ginkgo Bioworks is leveraging artificial intelligence to revolutionize its operations in the biotech industry, focusing on efficient data generation and analysis for biomanufacturing. Despite its ambitious plans and potential for groundbreaking advancements, the company is currently facing significant financial challenges, reporting a steep loss in Q2. Investors are advised to monitor Ginkgo's efforts to cut costs and attract more customers before considering an investment.
Source: YAHOO